Press Releases Filter Filter Results Year 2024 (1) 2023 (5) 2022 (23) 2021 (17) 2020 (38) 2019 (36) 2018 (23) 2017 (25) 2016 (20) 2015 (25) 2014 (26) 2013 (31) 2012 (35) May 3, 2016 Abiomed Announces Q4 FY 2016 Revenue of $94.0 Million, Up 39% Over Prior Year April 12, 2016 Abiomed Fourth Quarter Fiscal 2016 Earnings and Conference Call Notification April 12, 2016 Abiomed Impella Devices Support 37,673 Patients, Enough to Fill Historic Fenway Park April 7, 2016 Abiomed Impella® Therapy Receives FDA Approval for Cardiogenic Shock After Heart Attack or Heart Surgery February 8, 2016 Abiomed Announces Appointments of Jeannine Rivet and Christopher Van Gorder to Board of Directors February 4, 2016 Abiomed Announces Q3 FY 2016 Revenue of $85.8 Million, Up 38% Over Prior Year January 26, 2016 Abiomed Third Quarter Fiscal 2016 Earnings and Conference Call Notification January 11, 2016 Abiomed Announces Preliminary Q3 FY 2016 Revenue of $85.8 Million, Up 38% Over Prior Year December 29, 2015 Abiomed to Present at the 34th Annual J.P. Morgan Healthcare Conference October 29, 2015 Abiomed Announces Q2 FY 2016 Revenue of $76.4 Million, Up 47% Over Prior Year October 8, 2015 Abiomed to Appoint Seth Bilazarian, M.D., New Vice President of Interventional Cardiology Programs October 8, 2015 Abiomed Second Quarter Fiscal 2016 Earnings and Conference Call Notification October 8, 2015 Abiomed's Impella(R) Technology Showcased at TCT 2015 With Over 25 Presentations in the Scientific Sessions September 10, 2015 Abiomed to Present at the Morgan Stanley Global Healthcare Conference August 17, 2015 Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0/LD Pre-Market Approval Supplements … 12 13 14 15 …